Systemic Therapy for Unresectable Hepatocellular Carcinoma: Present Landscape and Future Challenges
<p>The World Health Organization’s global health estimates in 2022 showed that primary liver cancer ranks as the sixth most common cancer globally, impacting over 866,000 patients worldwide, and is the third leading cause of cancer death globally, with a higher prevalence in Asia. Hepatocellul...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2026
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1237192 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Systemic Therapy for Unresectable Hepatocellular Carcinoma: Present Landscape and Future Challenges
- Radioembolization for the Treatment of Unresectable Hepatocellular Carcinoma
- Transcatheter Arterial Chemo-Embolization with a Fine-Powder Formulation of Cisplatin for Unresectable Hepatocellular Carcinoma
- Systemic Therapy in Hepatocellular Carcinoma
- Image-Guided Therapies for Hepatocellular Carcinoma in Hepatocelluar Carcinoma — Future Outlook
- Patient Selection and Treatment Consideration in Metastatic Colorectal Cancer
- Targeted Therapies for Hepatocellular Carcinoma Treatment